D'URSI, PASQUALINA
D'URSI, PASQUALINA
A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17
2017-01-01 Giagulli, Cinzia; D'Ursi, Pasqualina; He, Wangxiao; Zorzan, Simone; Caccuri, Francesca; Varney, Kristen; Orro, Alessandro; Marsico, Stefania; Otjacques, Benoã®t; Laudanna, Carlo; Milanesi, Luciano; Dolcetti, Riccardo; Fiorentini, Simona; Lu, Wuyuan; Caruso, Arnaldo
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein
2023-01-01 Strizzi, Sergio; Bernardo, Letizia; D'Ursi, Pasqualina; Urbinati, Chiara; Bianco, Andrea; Limanaqi, Fiona; Manconi, Andrea; Milanesi, Maria; Macchi, Alberto; Di Silvestre, Dario; Cavalleri, Adalberto; Pareschi, Giovanni; Rusnati, Marco; Clerici, Mario; Mauri, Pierluigi; Biasin, Mara
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
2021-01-01 Rusnati, M.; Paiardi, G.; Tobia, C.; Urbinati, C.; Lodola, A.; D'Ursi, P.; Corrado, M.; Castelli, R.; Wade, R. C.; Tognolini, M.; Chiodelli, P.
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host
2022-01-01 Caccuri, Francesca; Messali, Serena; Bortolotti, Daria; Di Silvestre, Dario; De Palma, Antonella; Cattaneo, Chiara; Bertelli, Anna; Zani, Alberto; Milanesi, Maria; Giovanetti, Marta; Campisi, Giovanni; Gentili, Valentina; Bugatti, Antonella; Filippini, Federica; Scaltriti, Erika; Pongolini, Stefano; Tucci, Alessandra; Fiorentini, Simona; D'Ursi, Pasqualina; Ciccozzi, Massimo; Mauri, Pierluigi; Rizzo, Roberta; Caruso, Arnaldo
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound
2019-01-01 Chiodelli, P.; Paiardi, G.; Urbinati, C.; Lodola, A.; Tognolini, M.; D'Ursi, P.; Corrado, M.; Rusnati, M.
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue
2019-01-01 D'Ursi, P.; Uggeri, M.; Urbinati, C.; Millo, E.; Paiardi, G.; Milanesi, L.; Ford, R. C.; Clews, J.; Meng, X.; Bergese, P.; Ridolfi, Andrea; Pedemonte, N.; Fossa, P.; Orro, A.; Rusnati, M.
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications
2019-01-01 Bugatti, Antonella; Paiardi, Giulia; Urbinati, Chiara; Chiodelli, Paola; Orro, Alessandro; Uggeri, Matteo; Milanesi, Luciano; Caruso, Arnaldo; Caccuri, Francesca; D'Ursi, Pasqualina; Rusnati, Marco
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications
2019-01-01 Paiardi, G.; Bugatti, A.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Caruso, A.; Caccuri, F.; D'Ursi, P.; Rusnati, M.
HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions
2021-01-01 Milanesi, M.; Chiodelli, P.; Urbinati, C.; Manconi, A.; D'Ursi, P.; Rusnati, M.
HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension
2021-01-01 Milanesi, M; Chiodelli, P; Urbinati, C; Manconi, A; D'Ursi, P; Rusnati, M
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study
2019-01-01 Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; D'Ursi, P.; Rusnati, M.
implementation of an incremental docking method to study long sugar chains interactions with proteins
2019-01-01 Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; Rusnati, M.; D'Ursi, P.
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library
2021-01-01 Orro, A.; Uggeri, M.; Rusnati, M.; Urbinati, C.; Pedemonte, N.; Pesce, E.; Moscatelli, M.; Padoan, R.; Cichero, E.; Fossa, P.; D'Ursi, P.
multidisciplinary approaches to rescue CFTR impairments by drug repositioning
2019-01-01 Uggeri, M.; Orro, A.; Urbinati, C.; Millo, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M.; D'Ursi, P.
Recent Strategic Advances in CFTR Drug Discovery: An Overview
2020-01-01 Rusnati, Marco; D'Ursi, Pasqualina; Pedemonte, Nicoletta; Urbinati, Chiara; Ford, Robert C; Cichero, Elena; Uggeri, Matteo; Orro, Alessandro; Fossa, Paola
rescuing defective CFTR applying a drug repositioning strategy
2019-01-01 Uggeri, M.; Orro, A.; Millo, E.; Cichero, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Rusnati, M.; D'Ursi, P.; Fossa, P.
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays
2020-01-01 Fossa, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Rondina, A.; Nale, V.; Milanesi, M.; Pedemonte, N.; D'Ursi, P.; Rusnati, M.
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays
2019-01-01 D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M.
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays
2018-01-01 D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Fossa, P.; Rusnati, M.
Role of Q675H mutation in improving SARS-CoV-2 spike interaction with the furin binding pocket
2021-01-01 Bertelli, A.; D'Ursi, P.; Campisi, G.; Messali, S.; Milanesi, M.; Giovanetti, M.; Ciccozzi, M.; Caccuri, F.; Caruso, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17 | 1-gen-2017 | Giagulli, Cinzia; D'Ursi, Pasqualina; He, Wangxiao; Zorzan, Simone; Caccuri, Francesca; Varney, Kristen; Orro, Alessandro; Marsico, Stefania; Otjacques, Benoã®t; Laudanna, Carlo; Milanesi, Luciano; Dolcetti, Riccardo; Fiorentini, Simona; Lu, Wuyuan; Caruso, Arnaldo | |
| An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein | 1-gen-2023 | Strizzi, Sergio; Bernardo, Letizia; D'Ursi, Pasqualina; Urbinati, Chiara; Bianco, Andrea; Limanaqi, Fiona; Manconi, Andrea; Milanesi, Maria; Macchi, Alberto; Di Silvestre, Dario; Cavalleri, Adalberto; Pareschi, Giovanni; Rusnati, Marco; Clerici, Mario; Mauri, Pierluigi; Biasin, Mara | |
| Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin | 1-gen-2021 | Rusnati, M.; Paiardi, G.; Tobia, C.; Urbinati, C.; Lodola, A.; D'Ursi, P.; Corrado, M.; Castelli, R.; Wade, R. C.; Tognolini, M.; Chiodelli, P. | |
| Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host | 1-gen-2022 | Caccuri, Francesca; Messali, Serena; Bortolotti, Daria; Di Silvestre, Dario; De Palma, Antonella; Cattaneo, Chiara; Bertelli, Anna; Zani, Alberto; Milanesi, Maria; Giovanetti, Marta; Campisi, Giovanni; Gentili, Valentina; Bugatti, Antonella; Filippini, Federica; Scaltriti, Erika; Pongolini, Stefano; Tucci, Alessandra; Fiorentini, Simona; D'Ursi, Pasqualina; Ciccozzi, Massimo; Mauri, Pierluigi; Rizzo, Roberta; Caruso, Arnaldo | |
| direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound | 1-gen-2019 | Chiodelli, P.; Paiardi, G.; Urbinati, C.; Lodola, A.; Tognolini, M.; D'Ursi, P.; Corrado, M.; Rusnati, M. | |
| Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue | 1-gen-2019 | D'Ursi, P.; Uggeri, M.; Urbinati, C.; Millo, E.; Paiardi, G.; Milanesi, L.; Ford, R. C.; Clews, J.; Meng, X.; Bergese, P.; Ridolfi, Andrea; Pedemonte, N.; Fossa, P.; Orro, A.; Rusnati, M. | |
| Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications | 1-gen-2019 | Bugatti, Antonella; Paiardi, Giulia; Urbinati, Chiara; Chiodelli, Paola; Orro, Alessandro; Uggeri, Matteo; Milanesi, Luciano; Caruso, Arnaldo; Caccuri, Francesca; D'Ursi, Pasqualina; Rusnati, Marco | |
| heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications | 1-gen-2019 | Paiardi, G.; Bugatti, A.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Caruso, A.; Caccuri, F.; D'Ursi, P.; Rusnati, M. | |
| HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions | 1-gen-2021 | Milanesi, M.; Chiodelli, P.; Urbinati, C.; Manconi, A.; D'Ursi, P.; Rusnati, M. | |
| HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension | 1-gen-2021 | Milanesi, M; Chiodelli, P; Urbinati, C; Manconi, A; D'Ursi, P; Rusnati, M | |
| implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study | 1-gen-2019 | Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; D'Ursi, P.; Rusnati, M. | |
| implementation of an incremental docking method to study long sugar chains interactions with proteins | 1-gen-2019 | Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; Rusnati, M.; D'Ursi, P. | |
| In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library | 1-gen-2021 | Orro, A.; Uggeri, M.; Rusnati, M.; Urbinati, C.; Pedemonte, N.; Pesce, E.; Moscatelli, M.; Padoan, R.; Cichero, E.; Fossa, P.; D'Ursi, P. | |
| multidisciplinary approaches to rescue CFTR impairments by drug repositioning | 1-gen-2019 | Uggeri, M.; Orro, A.; Urbinati, C.; Millo, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M.; D'Ursi, P. | |
| Recent Strategic Advances in CFTR Drug Discovery: An Overview | 1-gen-2020 | Rusnati, Marco; D'Ursi, Pasqualina; Pedemonte, Nicoletta; Urbinati, Chiara; Ford, Robert C; Cichero, Elena; Uggeri, Matteo; Orro, Alessandro; Fossa, Paola | |
| rescuing defective CFTR applying a drug repositioning strategy | 1-gen-2019 | Uggeri, M.; Orro, A.; Millo, E.; Cichero, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Rusnati, M.; D'Ursi, P.; Fossa, P. | |
| rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays | 1-gen-2020 | Fossa, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Rondina, A.; Nale, V.; Milanesi, M.; Pedemonte, N.; D'Ursi, P.; Rusnati, M. | |
| rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays | 1-gen-2019 | D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M. | |
| rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays | 1-gen-2018 | D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Fossa, P.; Rusnati, M. | |
| Role of Q675H mutation in improving SARS-CoV-2 spike interaction with the furin binding pocket | 1-gen-2021 | Bertelli, A.; D'Ursi, P.; Campisi, G.; Messali, S.; Milanesi, M.; Giovanetti, M.; Ciccozzi, M.; Caccuri, F.; Caruso, A. |